Collectively, these findings clearly demonstrate that CD163+ TIM4+ macrophages in the omentum represent a distinct tissue-specific cellular subset crucial for ovarian cancer metastasis, highlighting their potential as therapeutic targets or prognostic biomarkers for ovarian cancer. This evidence concerns the gene CD163 and ovarian carcinoma.